Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials.
Bar-Or A, Thanei GA, Harp C, Bernasconi C, Bonati U, Cross AH, Fischer S, Gaetano L, Hauser SL, Hendricks R, Kappos L, Kuhle J, Leppert D, Model F, Sauter A, Koendgen H, Jia X, Herman AE. Bar-Or A, et al. Among authors: herman ae. EBioMedicine. 2023 Jul;93:104662. doi: 10.1016/j.ebiom.2023.104662. Epub 2023 Jun 22. EBioMedicine. 2023. PMID: 37354600 Free PMC article. Clinical Trial.
Effect of Ocrelizumab on B- and T-Cell Receptor Repertoire Diversity in Patients With Relapsing Multiple Sclerosis From the Randomized Phase III OPERA Trial.
Laurent SA, Strauli NB, Eggers EL, Wu H, Michel B, Demuth S, Palanichamy A, Wilson MR, Sirota M, Hernandez RD, Cree BAC, Herman AE, von Büdingen HC. Laurent SA, et al. Among authors: herman ae. Neurol Neuroimmunol Neuroinflamm. 2023 Apr 24;10(4):e200118. doi: 10.1212/NXI.0000000000200118. Print 2023 Jul. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37094998 Free PMC article. Clinical Trial.
Development of a novel, highly sensitive assay for quantification of minimal residual B cells in autoimmune disease and comparison to traditional methods across B-cell-depleting agents.
Looney CM, Strauli N, Cascino MD, Garma H, Schroeder AV, Takahashi C, O'Gorman W, Green C, Herman AE. Looney CM, et al. Among authors: herman ae. Clin Immunol. 2023 Mar;248:109265. doi: 10.1016/j.clim.2023.109265. Epub 2023 Feb 14. Clin Immunol. 2023. PMID: 36796471 Free article.
Microlearning and Social Media: A Novel Approach to Video-Based Learning and Surgical Education.
Palmon I, Brown CS, Highet A, Kulick AA, Barrett ME, Cassidy DE, Herman AE, Gomez-Rexrode AE, O'Reggio R, Sonnenday C, Waits SA, Wakam GK. Palmon I, et al. Among authors: herman ae. J Grad Med Educ. 2021 Jun;13(3):323-326. doi: 10.4300/JGME-D-20-01562.1. Epub 2021 Jun 14. J Grad Med Educ. 2021. PMID: 34178254 Free PMC article. No abstract available.
Fostering Passion and Skills in Surgical Research Across the Medical Education Continuum: The Transplant Research, Education, and Engagement Group.
Highet A, Gomez-Rexrode AE, Barrett M, Santos-Parker KS, Santos-Parker JR, Cassidy DE, Herman AE, Kulick AA, Brown CS, Montgomery JR, Wakam GK, Englesbe MJ, Waits SA. Highet A, et al. Among authors: herman ae. J Surg Educ. 2021 Jan-Feb;78(1):356-360. doi: 10.1016/j.jsurg.2020.07.006. Epub 2020 Jul 29. J Surg Educ. 2021. PMID: 32739442 Free PMC article.
Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC-0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor.
Herman AE, Chinn LW, Kotwal SG, Murray ER, Zhao R, Florero M, Lin A, Moein A, Wang R, Bremer M, Kokubu S, Serone AP, Hanze EL, Viberg A, Morimoto AM, Winter HR, Katsumoto TR. Herman AE, et al. Clin Pharmacol Ther. 2018 Jun;103(6):1020-1028. doi: 10.1002/cpt.1056. Epub 2018 Mar 23. Clin Pharmacol Ther. 2018. PMID: 29484638 Clinical Trial.
27 results